These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 27998761)

  • 1. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
    Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis.
    Wang J; Chen Y; Wang Q; Xu H; Jiang Q; Wang M; Li S; Chen Y; Wu C; Yu P; Xiao Z; Chen W; Lan Q
    Cancer Med; 2023 Mar; 12(6):7309-7326. PubMed ID: 36479622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA
    Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA SPRY4-IT1 promotes proliferation and invasion by acting as a ceRNA of miR-101-3p in colorectal cancer cells.
    Jin J; Chu Z; Ma P; Meng Y; Yang Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716250. PubMed ID: 28720069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma.
    Wen X; Han XR; Wang YJ; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Wu Q; Tan JH; Wu DM; Lu J; Zheng YL
    J Cell Biochem; 2018 Feb; 119(2):1827-1840. PubMed ID: 28796375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
    Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
    J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
    Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
    J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression.
    Yang L; Cheng X; Ge N; Guo W; Feng F; Wan F
    Oncotarget; 2017 Jan; 8(2):3104-3110. PubMed ID: 27902971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA SPRY4-IT1 Modulates Ketamine-Induced Neurotoxicity in Human Embryonic Stem Cell-Derived Neurons through EZH2.
    Huang J; Xu Y; Wang F; Wang H; Li L; Deng Y; Cai L
    Dev Neurosci; 2021; 43(1):9-17. PubMed ID: 33827085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
    Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer.
    Cao S; Lin L; Xia X; Wu H
    Mol Ther Nucleic Acids; 2019 Sep; 17():455-464. PubMed ID: 31330497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference from LncRNA SPRY4-IT1 restrains the proliferation, migration, and invasion of melanoma cells through inactivating MAPK pathway by up-regulating miR-22-3p.
    Li Z; Tang X; Duan S
    Int J Clin Exp Pathol; 2019; 12(2):477-487. PubMed ID: 31933852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.